LB2101 / Legend Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LB2101 / Legend Biotech
NCT05352542: GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma

Terminated
1
10
RoW
GPC3 Targeting CART Cells
jianming xu, Nanjing Legend Biotech Co.
Advanced Hepatocellular Carcinoma
07/24
07/24

Download Options